Generalized Estimating Equations (GEE) analyses showed that differences between the groups considered over one year were statistically significant regarding an improvement in pain (p = 0.002), and disability on CPQ (p = 0.005) and disability on WDQ (p < 0.001), favoring the Index Group.
The findings of the present study were that the clinically and statistically significant differences in pain intensity and disability between the groups remained at 26 and 52 weeks, and that the differences between the groups considered over one year were statistically significant (p < 0.01) also when consideration was taken to the covariance between the repeated measurements.
Similarly, total microbial growth did not differ between the two groups considering the tracheal aspirate samples collected before extubation.
Also, despite adjusting for proxy indicators, e.g., wealth, exposure to infection might still have differed between the study groups, considering the patchy malaria transmission in Kumasi (6 ).
Figure 2 illustrates the cumulative probability function showing the likelihood of cost difference between the two groups considering hospitalizations due to HF and LV lead surgical revision.
CI was significantly different between the two groups considering that mean VIS at PCICU admission was similar (p = 0.29).
There were no differences between the two groups considering age, histology, nuclear grade, lymph vascular invasion (LVI), downstaging after NAC based on pathological response, use of hormonal therapy, Ki-67 index, and percentage of ER and PgR.
Glycemic outcomes measured with CGM showed no significant differences between treatment groups (considering the multiple outcomes assessed) with respect to percent of values within, above, and below the target range (Table 2 and Supplementary Table A2).
